Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-784-4 | CAS number: 110-62-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2000-10-09 - 2001-02-13
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Remarks:
- Experimental Toxicology and Ecology, BASF AG
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Isovaleraldehyde
- EC Number:
- 209-691-5
- EC Name:
- Isovaleraldehyde
- Cas Number:
- 590-86-3
- Molecular formula:
- C5H10O
- IUPAC Name:
- 3-methylbutanal
- Test material form:
- liquid
- Details on test material:
- - Name of test material (as cited in study report): Isovaleraldehyde
- Purity: 99.3 % (GC)
- Batch No.: Continuous production, Kol 4321 Seit.
- Test substance No.: 00/0558-1
- Date of manufacture: 27 Jul 2000
- Physical state: Colorless liquid
- Storage : Room temperature (N2 conditions)
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Deutschland
- Age at study initiation: 5 - 8 weeks
- Weight at study initiation: mean ca. 28 g
- Assigned to test groups randomly: yes
- Housing: housed individually in Makrolon cages, type MI
- Diet (e.g. ad libitum): ad libitum, Kliba Haltungsdiät, Provimi Kliba SA, Kaiseraugst, Switzerland
- Water (e.g. ad libitum): ad libitum, drinking water from bottles
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: Due to the limited solubility of the test substance in water, DMSO was selected as the vehicle, which had been demonstrated to be suitable in the in vivo micronucleus test and for which historical data are available. - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
All test substance formulations were prepared immediately before administration - Duration of treatment / exposure:
- single injection
- Frequency of treatment:
- one single application
- Post exposure period:
- 24, 48 h
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 25, 50, 100 mg/kg bw
Basis:
nominal conc.
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide (CPP), 20 mg/kg body weight for clastogenic effects
Vincristirie Sulphate (VCR), 0,15 mg/kg body weight for aneugenic effects
- Justification for choice of positive control(s): The stability of CPP and VCR is well-defined under the selected conditions, since both positive control articles are well-defined clastogens and aneugens respectively
- Route of administration: intraperitoneally
Examinations
- Tissues and cell types examined:
- polychromatic and normochromatic erythrocytes of bone marrow
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
In a pretest for the determination of the acute intraperitoneal toxicity, deaths were observed down to a dose of 150 mg/kg body weight. 100 mg/kg body weight were survived by all animals but led to evident signs of toxicity such as piloerection, squatting posture, and the general state of the animals was poor, however, showing no distinct symptomatic differences between the male and female animals.
Thus, only male animals were used for the cytogenetic investigations.
Therefore, a dose of 100 mg/kg body weight was selected as the highest dose in the present cytogenetic study. 50 mg/kg and 25 mg/kg body weight were administered as further doses.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
The animals were treated once and samples of bone marrow were taken 24 hours and 48 hours after the treatment
- The low dose group was given 25 mg test substance/kg body weight or 4 ml/kg body weight of a solution with a concentration of 0.625 g/100 ml.
- The intermediate dose group was given 50 mg test substance/kg body weight or 4 ml/kg body weight of a solution with a concentration of 1.25 g/100 ml.
- The top dos~: groups were given 100 mg test substance/kg body weight or 4 ml/kg body weight of a solution with a concentration of 2.5 g/100 ml
DETAILS OF SLIDE PREPARATION:
The bone marrow was prepared according to the method described by SCHMID (1976):
- The two femora were prepared by dissection and removing all soft tissues.
After cutting off the epiphyses, the bone marrow was flushed out of the diaphysis into a centrifuge tube using a cannula filled with fetal calf serum which was at 37°C (about 2 ml/femur). The suspension was mixed thoroughly with a pipette, centrifuged at 300 x g for 5 minutes, the supernatant was removed and the precipitate was resuspended in about 50 pl fresh FCS. 1 drop of this suspension was dropped onto clean microscopic slides, using a Pasteur pipette. Smears were prepared using slides with ground edges, the preparations were dried in the air and subsequently stained.
METHOD OF ANALYSIS:
In general, 2000 polychromatic erythrocytes (PCE) from each of the male animals of every test group are evaluated and investigated for micronuclei (MN). The normochromatic erythrocytes (NCE) which occur are also scored. - Evaluation criteria:
- The test chemical is to be considered positive in this assay if the following criteria are met:
- A dose-relatod and significant increase in the number of micronucleated polychromatic erythrocytes at any of the intervals.
- The proportion of cells containing micronuclei exceeded both the values of the concurrent negative control range and the negative historical control range.
A test substance is generally considered negative in this test system if:
- There was no significant increase in the number of micronucleated polychromatic erythrocytes at any dose above concurrent control frequencies and at any time.
- The frequencies of cells containing micronuclei were within the historical control range. - Statistics:
- The statistical evaluation of the data was carried out using the program system MUKERN (BASF Aktiengesellschaft) .
The number of micronuclei in polychromatic erythrocytes was analyzed. A comparison of the dose group with the vehicle control was carried out using the Wilcoxon test for the hypothesis of equal medians. Here, the relative frequencies of cells with micronuclei of each animal were used. If the results of this test were significant, labels (* for p <= 0.05, ** for p >= 0.01) were printed with the group means in the tables.
This test was performed one-sided.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- squatting, poor general state, piloerection
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 150, 100 mg/kg bw
- Clinical signs of toxicity in test animals: piloerection, squatting posture, and the general state of the animals was poor
Any other information on results incl. tables
The administration of the test substance led to evident signs of toxicity:
- 25 mg/kg bw:
1, 2 and 4 h: squatting posture; 1 d: no symptoms
- 50 mg/kg bw:
1 h: squatting posture; 2 and 4 h: squatting posture and poor general state; 1 d: no symptoms
- 100 mg/kg bw:
1 h: squatting posture and poor general state, 2 and 4 h:
squatting posture, poor general state and piloerection;
1 d: poor general state and piloerection
Results:
Test group | Interval: 24 h | Interval: 48 h | ||||||
Polychromatic erythrocytes | Normocytes / total amount polychromatic erythrocytes | Cells with micronuclei (%) | Polychromatic erythrocytes | Normocytes / total amount polychromatic erythrocytes | Cells with micronuclei (%) | |||
Dose (mg/kg bw) | polychromatic | normochromatic | polychromatic | normochromatic | ||||
vehicle control | 10000 | 3396 | 1.3 | 0.3 | 100000 | 2974 | 1.7 | 1.0 |
25 | 10000 | 3997 | 1.3 | 1.5 | ||||
50 | 10000 | 3764 | 2.2 | 2.9 | ||||
100 | 10000 | 3769 | 1.9 | 1.6 | 10000 | 4193 | 0.9 | 1.0 |
20, cyclophosphamide | 10000 | 3092 | 21.5** | 3.6 | ||||
0.15, vincristine | 10000 | 4859 | 49.7** | 2.3 |
* p<=0.05; ** p<= 0.01
There was no increase in the number of polychromatic erythrocytes containing either small or large micronuclei.
The rate of microneuclei was nearly the range of the concurrent negative control in all dose groups and within the range of the historical control data.
No inhibition of erythropoiesis, determined from the ratio of polychromatic to normochromatic erythrocytes, was detected.
The result for the negative control was within the historical control range.
Both of the positive control chemicals, i.e. cyclophosphamide for clastogenic effects and vincristine for induction of spindle poison effects, induced the expected increases in the rate of polychromatic erythrocytes containing small or large micronuclei.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
The test substance had no chromosome-damaging (clastogenic) effect, and there were no indications of any impairment of chromosome distribution in the course of mitosis (aneugenic activity) in bone marrow cells in vivo. - Executive summary:
In this in vivo micronucleus test (according to OECD Guideline 474, GLP), 5 male mice (strain: NMRI) were dosed intraperitoneally with the test item isovaleraldehyde. Test doses were 0, 25, 50, 100 mg/kg bw. The top dose was selected based on a pretest were mortality was observed down to a dose of 150 mg/kg bw and 100 mg/kg bw was survived by all animals but led to signs of toxicity. The animals were treated once and samples of bone marrow were taken 24 hours and 48 hours after the treatment. In general, 2000 polychromatic erythrocytes (PCE) from each of the male animals of every test group are evaluated and investigated for micronuclei (MN). The normochromatic erythrocytes (NCE) which occur were also scored.
There was no increase in the number of polychromatic erythrocytes containing either small or large micronuclei. The rate of microneuclei was nearly the range of the concurrent negative control in all dose groups and within the range of the historical control data. No inhibition of erythropoiesis, determined from the ratio of polychromatic to normochromatic erythrocytes, was detected.
The result for the negative control was within the historical control range. According to this study, the test item is considered to be not chromosome-damaging (clastogenic) effect, and does not lead to any impairment of chromosome distribution in the course of mitosis (aneugenic activity).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.